Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport

被引:119
作者
Zhang, SZ [1 ]
Yang, XN [1 ]
Morris, ME [1 ]
机构
[1] SUNY Buffalo, Univ Buffalo, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Buffalo, NY 14260 USA
关键词
BCRP; drug interaction; flavonoids; Loewe additivity; MDR reversal;
D O I
10.1023/B:PHAM.0000033015.84146.4c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of this study was to determine the dynamic parameter (EC50) of flavonoids apigenin, biochanin A, chrysin, genistein, kaempferol, hesperetin, naringenin, and silymarin for breast cancer resistance protein ( BCRP) inhibition when used alone, and to evaluate their potential interactions ( additive, synergistic, or antagonistic) with regards to BCRP inhibition when used in multiple-flavonoid combinations. Methods. The effects of flavonoids on BCRP-mediated transport were examined by evaluating their effects on mitoxantrone accumulation and cytotoxicity in MCF-7 MX100 cells overexpressing BCRP. The EC50 values of these flavonoids for increasing mitoxantrone accumulation were estimated using a Hill equation. The potential interactions among multiple flavonoids with regard to BCRP inhibition were assessed by isobologram and Berenbaum's interaction index methods. Results. The EC50 values of these flavonoids for increasing mitoxantrone accumulation ranged from 0.39 +/- 0.13 muM to 33.7 +/- 2.78 muM. Quantitative analysis of the combined effects of multiple flavonoids on mitoxantrone accumulation indicated that these flavonoids act additively in inhibiting BCRP when given as 2-, 3-, 5-, or 8-flavonoid combinations with equimolar concentrations of all constituents. The results of the mitoxantrone cytotoxicity studies were consistent with these findings. Conclusions. The additive effects of multiple flavonoids for BCRP inhibition suggests that prediction of BCRP-mediated food ( herbal product)-drug interactions should also take into consideration the presence of multiple flavonoids and provides a rationale for using "flavonoid cocktails" as a potential approach for multidrug resistance reversal in cancer treatment.
引用
收藏
页码:1263 / 1273
页数:11
相关论文
共 46 条
[1]  
Allikmets R, 1998, CANCER RES, V58, P5337
[2]   Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients [J].
Bailey, DG ;
Dresser, GR ;
Kreeft, JH ;
Munoz, C ;
Freeman, DJ ;
Bend, JR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (05) :468-477
[3]  
BERENBAUM MC, 1977, CLIN EXP IMMUNOL, V28, P1
[4]   Localisation of breast cancer resistance protein in microvessel endothelium of human brain [J].
Cooray, HC ;
Blackmore, CG ;
Maskell, L ;
Barrand, MA .
NEUROREPORT, 2002, 13 (16) :2059-2063
[5]   PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS [J].
DAVIES, B ;
MORRIS, T .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :1093-1095
[6]   A multidrug resistance transporter from human MCF-7 breast cancer cells [J].
Doyle, LA ;
Yang, WD ;
Abruzzo, LV ;
Krogmann, T ;
Gao, YM ;
Rishi, AK ;
Ross, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15665-15670
[7]   Perceptions about complementary therapies relative to conventional therapies among adults who use both: Results from a national survey [J].
Eisenberg, DM ;
Kessler, RC ;
Van Rompay, MI ;
Kaptchuk, TJ ;
Wilkey, SA ;
Appel, S ;
Davis, RB .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (05) :344-351
[8]   Isobolographic analysis of interactions: An update on applications and utility [J].
Gessner, PK .
TOXICOLOGY, 1995, 105 (2-3) :161-179
[9]  
GRECO WR, 1995, PHARMACOL REV, V47, P331
[10]   The biochemistry and medical significance of the flavonoids [J].
Havsteen, BH .
PHARMACOLOGY & THERAPEUTICS, 2002, 96 (2-3) :67-202